Dermatology Clinical Trials and Clinical Research
University Hospitals dermatology department currently has a critical mass in four major centers of excellence: cancer, photomedicine, immunology and mycology.
In cancer, we established interdisciplinary care programs to complement our existing expertise in cutaneous lymphomas and melanomas, chemical carcinogenesis, and mechanisms and therapy of skin cancer.
In photomedicine, the department is renowned worldwide for its work on how UV and visible light rays affect the skin, in particular photobiology, photoimmunology, photocarcinogenesis, reversal of UV injury and photodynamic therapy.
In immunology, faculty in our department are major leaders in the areas of psoriasis pathogenesis, immunodeficiency, atopic dermatitis/eczema, contact dermatitis, autoimmunity, and immuno-therapeutics.
In addition, the department sponsors an internationally recognized Center for Medical Mycology at University Hospitals. This latter center includes the Mycology Reference Laboratory, the Fungal Diseases Research Program, and Mycology Clinical Trials Unit.
Clinical Trials Unit
To bring the latest advances in science directly to our patients, we are committed to performing clinical trials of new therapeutics and to testing the performance of agents which modify the skin. Our Clinical Trials Unit is experienced in performing clinical trials of a variety of topical, oral or parenteral therapeutics. Complementing the Clinical Trials Unit is special expertise in skin disease outcome measurement.
A dedicated Skin Studies Center is equipped with noninvasive advanced skin assessment methodologies such as skin ultrasound, photography, image analysis, chromometer, Transepidermal Water Loss, and skin edema micrometers, as well as facilities for routine and keratome skin biopsies. The unit also contains photoradiometric instrumentation which is used to measure a full repertoire of solar simulators having narrow waveband and broadband light sources.
An important measure of the quality and national recognition of a program is the ability to obtain research grant funding from the National Institutes of Health (NIH). In both amount of funding and number of grants per Department, we are consistently ranked in the top ten nationally, clearly placing us in the very top echelon. Because NIH funding is so intensely competitive, it is very gratifying to obtain such recognition that our skin diseases research and training programs are among the premier efforts in the nation. This level of ranking recognizes the unique depth and breadth of our initiatives in advancing dermatologic health for our patients.
A Skin Diseases Research Center
A Skin Diseases Research Center coordinates our research efforts and creates the interconnectedness that makes our program a premier center for anyone wishing to work or train among a critical mass of faculty involved in cutaneous biology, skin diseases research, advanced clinical dermatology and education.